MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.8433
-0.0282 (-3.24%)
At close: May 8, 2026, 4:00 PM EDT
0.8500
+0.0067 (0.79%)
After-hours: May 8, 2026, 7:09 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $90.34 million as of May 8, 2026. Its market cap has decreased by -70.08% in one year.
Market Cap
90.34M
Enterprise Value
5.23M
1-Year Change
-70.08%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $90.34M, a decrease of -81.74%. That is a compound annual growth rate of -28.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 90.34M | -45.37% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AVITA Medical | 126.49M |
| Nano-X Imaging | 120.39M |
| Rapid Micro Biosystems | 120.37M |
| Neuronetics | 115.17M |
| QT Imaging Holdings | 84.54M |
| Sera Prognostics | 73.62M |
| Spectral AI | 73.51M |
| Xtant Medical Holdings | 72.84M |